New hope for early liver cancer: targeted radiation under the microscope
NCT ID NCT07278102
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 23 times
Summary
This study looks at how well a treatment called 90Y radioembolization works for people with early-stage liver cancer. About 200 patients in Korea will be followed to see how their tumors respond, how long they live, and what side effects occur. The goal is to gather real-world data to improve treatment guidelines and future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, Seoul, 03080, South Korea
Conditions
Explore the condition pages connected to this study.